Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · Real-Time Price · USD
0.474
-0.001 (-0.19%)
At close: Oct 31, 2024, 4:00 PM
0.463
-0.011 (-2.32%)
After-hours: Oct 31, 2024, 5:28 PM EDT

Turnstone Biologics Stock Forecast

TSBX's stock price has decreased by -80.81% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Turnstone Biologics stock have an average target of 4.75, with a low estimate of 0.50 and a high estimate of 10. The average target predicts an increase of 902.11% from the current stock price of 0.47.

Analyst Consensus: Buy
Target Low Average Median High
Price $0.50 $4.75 $3.75 $10
Change +5.49% +902.11% +691.14% +2009.7%

Analyst Ratings

The average analyst rating for TSBX stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating May '24Jun '24Jul '24Aug '24Sep '24Oct '24
Strong Buy 111111
Buy 111111
Hold 000001
Sell 000000
Strong Sell 000000
Total 222223

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
B of A Securities
B of A Securities
Hold
Downgrades
$10$0.5
Hold Downgrades $10$0.5 +5.49% Oct 14, 2024
B of A Securities
B of A Securities
Strong Buy
Maintains
$12$10
Strong Buy Maintains $12$10 +2,009.70% Aug 19, 2024
Piper Sandler
Piper Sandler
Buy
Maintains
$20$3.75
Buy Maintains $20$3.75 +691.14% Aug 19, 2024
B of A Securities
B of A Securities
Strong Buy
Initiates
$18
Strong Buy Initiates $18 +3,697.47% Aug 15, 2023
Piper Sandler
Piper Sandler
Buy
Initiates
$20
Buy Initiates $20 +4,119.41% Aug 15, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 19.31M
Revenue Next Year
n/a
EPS This Year
-3.98
from -4.78
EPS Next Year
-2.53
from -3.98
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028
Revenue
101.29M73.30M19.31M-----
Revenue Growth
--27.64%-73.66%-----
EPS
1.28-12.49-4.78-3.98-2.53-4.69--
EPS Growth
--------
Forward PE
--------
No. Analysts ---55444
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High n/a n/a n/a
Avg n/a n/a n/a
Low n/a n/a n/a

Revenue Growth

Revenue Growth 20242025202620272028
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 202420252026
High -3.72 -1.28 -4.83
Avg -3.98 -2.53 -4.69
Low -4.40 -3.67 -4.51

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.